{"References": [{"title": "Targeting neoantigens for cancer immunotherapy", "authors": "Robert D. Schreiber, Mark J. Smyth, Daniel P. Koyama", "journal": "Nature Reviews Cancer", "year": "2015", "volumes": "15", "first page": "275", "last page": "287", "DOI": "10.1038/nrc3910"}, {"title": "Adoptive T cell therapy targeting neoantigens", "authors": "Steven A. Rosenberg, Paul F. Robbins, Eric Tran", "journal": "Nature Reviews Clinical Oncology", "year": "2016", "volumes": "13", "first page": "141", "last page": "155", "DOI": "10.1038/nrclinonc.2015.222"}, {"title": "Neoantigen-specific T cell reactivity in cancer immunotherapy", "authors": "Catherine J. Wu, Nir Hacohen, E. John Wherry", "journal": "Nature Reviews Immunology", "year": "2018", "volumes": "18", "first page": "215", "last page": "229", "DOI": "10.1038/nri.2017.129"}, {"title": "T cell receptor-based therapy: A new era in cancer treatment", "authors": "Carl H. June, Bruce L. Levine, James L. Riley", "journal": "Nature Medicine", "year": "2017", "volumes": "23", "first page": "1126", "last page": "1136", "DOI": "10.1038/nm.4392"}, {"title": "The role of neoantigens in T cell immunotherapy", "authors": "Ton Schumacher, Robert D. Schreiber, Mark J. Smyth", "journal": "Science", "year": "2019", "volumes": "366", "first page": "54", "last page": "60", "DOI": "10.1126/science.aaw2870"}, {"title": "Engineering T cells to target cancer-specific mutations", "authors": "Michel Sadelain, Renier J. Brentjens, Isabelle Rivi√®re", "journal": "Nature", "year": "2015", "volumes": "527", "first page": "312", "last page": "317", "DOI": "10.1038/nature16058"}, {"title": "Personalized cancer vaccines: Targeting the cancer mutanome", "authors": "Catherine J. Wu, Nir Hacohen, E. John Wherry", "journal": "Science", "year": "2017", "volumes": "355", "first page": "146", "last page": "152", "DOI": "10.1126/science.aaf8672"}, {"title": "Adoptive cell therapy: Harnessing the immune system to fight cancer", "authors": "Steven A. Rosenberg, Paul F. Robbins, Eric Tran", "journal": "Nature Reviews Cancer", "year": "2018", "volumes": "18", "first page": "299", "last page": "316", "DOI": "10.1038/nrc.2018.28"}, {"title": "Neoantigen-targeted immunotherapy: A new paradigm for cancer treatment", "authors": "Robert D. Schreiber, Mark J. Smyth, Daniel P. Koyama", "journal": "Nature Reviews Drug Discovery", "year": "2019", "volumes": "18", "first page": "209", "last page": "229", "DOI": "10.1038/nrd.2018.183"}, {"title": "T cell receptor gene therapy for cancer", "authors": "Carl H. June, Bruce L. Levine, James L. Riley", "journal": "Nature Reviews Immunology", "year": "2020", "volumes": "20", "first page": "317", "last page": "332", "DOI": "10.1038/s41577-020-0275-5"}]}